2 active not recruiting, 1 completed, 1 terminated. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Active not recruiting 2, Completed 1, Terminated 1 |
Follow Alanine: new trials by email Literature Review of Alanine trials Research Report on Alanine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease Glycine, N-acetylcysteine, Alanine - Alzheimer Disease | Early Phase 1 | Active not recruiting | Baylor College of Medicine | 52 | 2022-02-15 | 2026-09-09 |
| Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 Glycine, N-acetylcysteine, Alanine - Covid19 | Early Phase 1 | Terminated | Baylor College of Medicine | 4 | 2021-01-11 | 2024-06-26 |
| Glutathione in Mild Cognitive Impairment Glycine, N-acetylcysteine (NAC), Alanine - Mild Cognitive Impairment | Early Phase 1 | Active not recruiting | Baylor College of Medicine | 60 | 2018-04-19 | 2026-09-04 |
| Glutathione and Fuel Oxidation in Aging Glycine, cysteine (as n-acetylcysteine), alanine - Aging | Early Phase 1 | Completed | Rajagopal V Sekhar | 36 | 2013-04-23 | 2023-02-15 |
Alzheimer Disease (1) · COVID-19 (1) · Cognitive Dysfunction (1)
Baylor College of Medicine (3) · Rajagopal V Sekhar (1)
United States (4)
R V Sekhar, MD (1) · Rajagopal V Sekhar, M.D. (1)
R01AG041782 (1)